Male Sexual Dysfunction Treatment: Nonpharmacologic
Cigna medical coverage policy 0403 governs nonpharmacologic treatments for male sexual dysfunction (erectile dysfunction), specifying medical necessity criteria for penile prosthesis implantation, and listing procedures considered not medically necessary (nerve grafting and application of amniotic-derived allografts to nerve bundles during radical prostatectomy). It also provides coding guidance and references.
Annual Review removed the policy statements for vacuum erection devices and extracorporeal shock wave therapy.
Annual Review removed the policy statement for venous occlusive surgery.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.